文献速递药物不良反应与药物警戒

药物警戒中的人工智能:CIOMS第十四工作组指导原则

Artificial Intelligence in Pharmacovigilance: Guiding Principles from the CIOMS Working Group XIV.
PubMed 文献 · Drug Saf · 2026-08-26

本文概述该指南并通过精选用例说明原则的实践应用,旨在帮助利益相关方在保持科学严谨性、透明度和公众信任的前提下开发部署AI系统。

要点

  • CIOMS第十四工作组提出药物警戒AI应用七项指导原则
  • 原则涵盖基于风险、人工监督、稳健性、透明度、隐私、公平与治理问责
  • AI可提升药物警戒效率但须确保监管决策与患者安全不受损害

核心结论

  • CIOMS第十四工作组发布药物警戒人工智能指导原则,以支持在维持科学严谨性、透明度和公众信任的同时负责任地开发部署AI系统。

主要发现

  • 报告提出七项指导原则:基于风险的方法、人工监督、有效性与稳健性、透明度、数据隐私、公平与公正、治理与问责。
  • 人工智能正被越来越多地探索用于支持药物警戒活动,包括涉及个例安全性报告处理的流程。

关键数值与推荐

  • 七项指导原则:基于风险的方法、人工监督、有效性与稳健性、透明度、数据隐私、公平与公正、治理与问责。

临床怎么用

  • 利益相关方可将七项原则应用于药物警戒AI系统的开发与部署,本文通过精选用例说明原则的实践应用方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Artificial intelligence (AI) is increasingly being explored to support pharmacovigilance activities including processes involving individual case safety reports. These technologies may improve efficiency and enable new analytical capabilities, but they also raise important questions regarding the responsible use of these systems in contexts that directly support regulatory decision-making and patient safety. In response to these opportunities and challenges, the Council for International Organizations of Medical Sciences (CIOMS) set up Working Group XIV on Artificial Intelligence in Pharmacovigilance to establish and promote principles and guidance for this area. The resulting CIOMS report was published in December 2025 and presents seven guiding principles: risk-based approach, human oversight, validity and robustness, transparency, data privacy, fairness and equity, and governance and accountability. To maximise stakeholder awareness and understanding, this article provides an overview of the CIOMS XIV guidance and illustrates how these principles may be applied in practice through selected use cases. The report aims to support stakeholders in developing and deploying AI systems in a manner that maintains scientific rigor, transparency, and public trust while enabling innovation to support safe use of medicines worldwide.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Norén GN, Durand J, Kara V, et al. Artificial Intelligence in Pharmacovigilance: Guiding Principles from the CIOMS Working Group XIV. Drug Saf. 2026. PMID: 42645766. doi:10.1007/s40264-026-01708-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。